Login / Signup

Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?

Li-Li CuiDominika GolubczykAnna-Maija TolppanenJohannes BoltzeJukka Jolkkonen
Published in: Annals of neurology (2019)
Keyphrases
  • cell therapy
  • stem cells
  • mesenchymal stem cells
  • atrial fibrillation
  • double blind
  • bone marrow